Autor: |
Bermúdez-Pirela, V, Souki, A, Cano-Ponce, C, Bermúdez-Arias, F, Mengual-Moreno, E, Leal-Gonzalez, E, Lemus-Antepaz, M, Cabrera de B, M, Amell de D, A, Leal de P, N, Cano-Peñaloza, R, Puche-Medina, G, Ramirez, I, Contreras, F, Velasco, M |
Jazyk: |
angličtina |
Rok vydání: |
2005 |
Předmět: |
|
Zdroj: |
Archivos Venezolanos de Farmacología y Terapéutica, Volume: 24, Issue: 2, Pages: 10-16, Published: 2005 |
Popis: |
Objective: Hypertriacylglyceridemia and low HDLc combination is one of the most common lipidic abnormalities. Thus, the aim of this study was to determine the effects of Ciprofibrate on patients with Frederickson’s Type IV dyslipidemia phenotype. Research design and methods: 75 patients with type IV dyslipidemia were assigned at random to one of two therapeutic options: Group A, AHA diet and physical activity and B, AHA diet, physical activity and Ciprofibrate 100 mg daily for 12 weeks. All patients underwent lipidic profile quantification before and after therapeutic intervention. Results: Ciprofibrate treatment group exhibited significantly reduction in total cholesterol (-14,2% vs. -4,8%; p |
Databáze: |
OpenAIRE |
Externí odkaz: |
|